
HQY Valuation
Healthequity Inc
- Overview
- Forecast
- Valuation
- Earnings
HQY Relative Valuation
HQY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HQY is overvalued; if below, it's undervalued.
Historical Valuation
Healthequity Inc (HQY) is now in the Undervalued zone, suggesting that its current forward PE ratio of 24.02 is considered Undervalued compared with the five-year average of 36.30. The fair price of Healthequity Inc (HQY) is between 90.52 to 159.33 according to relative valuation methord. Compared to the current price of 88.54 USD , Healthequity Inc is Undervalued By 2.19%.
Relative Value
Fair Zone
90.52-159.33
Current Price:88.54
2.19%
Undervalued
24.04
PE
1Y
3Y
5Y
Trailing
Forward
15.62
EV/EBITDA
Healthequity Inc. (HQY) has a current EV/EBITDA of 15.62. The 5-year average EV/EBITDA is 19.92. The thresholds are as follows: Strongly Undervalued below 11.10, Undervalued between 11.10 and 15.51, Fairly Valued between 24.33 and 15.51, Overvalued between 24.33 and 28.74, and Strongly Overvalued above 28.74. The current Forward EV/EBITDA of 15.62 falls within the Historic Trend Line -Fairly Valued range.
29.07
EV/EBIT
Healthequity Inc. (HQY) has a current EV/EBIT of 29.07. The 5-year average EV/EBIT is 148.18. The thresholds are as follows: Strongly Undervalued below -726.13, Undervalued between -726.13 and -288.98, Fairly Valued between 585.33 and -288.98, Overvalued between 585.33 and 1022.48, and Strongly Overvalued above 1022.48. The current Forward EV/EBIT of 29.07 falls within the Historic Trend Line -Fairly Valued range.
6.02
PS
Healthequity Inc. (HQY) has a current PS of 6.02. The 5-year average PS is 6.19. The thresholds are as follows: Strongly Undervalued below 4.12, Undervalued between 4.12 and 5.16, Fairly Valued between 7.22 and 5.16, Overvalued between 7.22 and 8.26, and Strongly Overvalued above 8.26. The current Forward PS of 6.02 falls within the Historic Trend Line -Fairly Valued range.
18.57
P/OCF
Healthequity Inc. (HQY) has a current P/OCF of 18.57. The 5-year average P/OCF is 27.47. The thresholds are as follows: Strongly Undervalued below 9.01, Undervalued between 9.01 and 18.24, Fairly Valued between 36.70 and 18.24, Overvalued between 36.70 and 45.92, and Strongly Overvalued above 45.92. The current Forward P/OCF of 18.57 falls within the Historic Trend Line -Fairly Valued range.
19.56
P/FCF
Healthequity Inc. (HQY) has a current P/FCF of 19.56. The 5-year average P/FCF is 42.29. The thresholds are as follows: Strongly Undervalued below -11.38, Undervalued between -11.38 and 15.45, Fairly Valued between 69.12 and 15.45, Overvalued between 69.12 and 95.96, and Strongly Overvalued above 95.96. The current Forward P/FCF of 19.56 falls within the Historic Trend Line -Fairly Valued range.
Healthequity Inc (HQY) has a current Price-to-Book (P/B) ratio of 3.79. Compared to its 3-year average P/B ratio of 3.28 , the current P/B ratio is approximately 15.64% higher. Relative to its 5-year average P/B ratio of 3.25, the current P/B ratio is about 16.81% higher. Healthequity Inc (HQY) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 3.52%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 3.21% , the current FCF yield is about -100.00% lower.
3.80
P/B
Median3y
3.28
Median5y
3.25
4.22
FCF Yield
Median3y
3.52
Median5y
3.21
Competitors Valuation Multiple
The average P/S ratio for HQY's competitors is 4.62, providing a benchmark for relative valuation. Healthequity Inc Corp (HQY) exhibits a P/S ratio of 6.02, which is 30.19% above the industry average. Given its robust revenue growth of 15.04%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of HQY increased by 12.20% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 10.02 to 16.30.
The secondary factor is the Revenue Growth, contributed 15.04%to the performance.
Overall, the performance of HQY in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

VERX
Vertex Inc
25.770
USD
-2.75%

GAP
Gap Inc
20.530
USD
-2.93%

INGR
Ingredion Inc
126.400
USD
-1.17%

FYBR
Frontier Communications Parent Inc
37.050
USD
-0.08%

U
Unity Software Inc
37.760
USD
-0.47%

FN
Fabrinet
317.625
USD
-5.84%

PLNT
Planet Fitness Inc
106.980
USD
-0.20%

TTAN
ServiceTitan Inc
101.930
USD
-0.55%

STN
Stantec Inc
104.800
USD
-3.62%

PEGA
Pegasystems Inc
52.365
USD
-0.99%
FAQ

Is Healthequity Inc (HQY) currently overvalued or undervalued?
Healthequity Inc (HQY) is now in the Undervalued zone, suggesting that its current forward PE ratio of 24.02 is considered Undervalued compared with the five-year average of 36.30. The fair price of Healthequity Inc (HQY) is between 90.52 to 159.33 according to relative valuation methord. Compared to the current price of 88.54 USD , Healthequity Inc is Undervalued By 2.19% .

What is Healthequity Inc (HQY) fair value?

How does HQY's valuation metrics compare to the industry average?

What is the current P/B ratio for Healthequity Inc (HQY) as of Aug 14 2025?

What is the current FCF Yield for Healthequity Inc (HQY) as of Aug 14 2025?

What is the current Forward P/E ratio for Healthequity Inc (HQY) as of Aug 14 2025?
